Your browser doesn't support javascript.
loading
Examining the evolving landscape of liver cancer burden in the United States from 1990 to 2019.
Al Ta'ani, Omar; Al-Ajlouni, Yazan; Jagdish, Balaji; Khataniar, Himsikhar; Aleyadeh, Wesam; Al-Bitar, Farah; Singh, Tavankit.
Afiliação
  • Al Ta'ani O; Allegheny Health Network, 320 E North Ave, Pittsburgh, PA, 15212, USA. otaani19@gmail.com.
  • Al-Ajlouni Y; School of Medicine, New York Medical College, NYC, NY, USA.
  • Jagdish B; Allegheny Health Network, 320 E North Ave, Pittsburgh, PA, 15212, USA.
  • Khataniar H; Allegheny Health Network, 320 E North Ave, Pittsburgh, PA, 15212, USA.
  • Aleyadeh W; Cleveland Clinic Akron General, Akron, OH, USA.
  • Al-Bitar F; Toronto Centre for Liver Disease, Toronto, ON, Canada.
  • Singh T; Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, MI, USA.
BMC Cancer ; 24(1): 1098, 2024 Sep 04.
Article em En | MEDLINE | ID: mdl-39232707
ABSTRACT

INTRODUCTION:

Liver cancer (LC) is frequently preceded by cirrhosis and poses a significant public health challenge in the United States (US). Recent decades have seen notable shifts in the epidemiological patterns of LC, yet national data guiding the optimal allocation of resources and preventive efforts remain limited. This study aims to investigate the current trends, risk factors, and outcomes of LC in the US.

METHODS:

This study utilized the Global Burden of Disease (GBD) dataset to collect data on the annual incident cases, deaths, Disability-Adjusted Life Years (DALYs), age-standardized incidence rates (ASIR), age-standardized death rates, and age-standardized DALY rates of primary LC and its etiologies and risk factors, between 1990 and 2019. Percentage changes in incident cases, DALYs, and deaths and the estimated annual percentage change (EAPC) in ASIR and deaths rates of LC were calculated to conduct temporal analysis. Linear regression was applied for the calculation of EAPCs. Correlations of EAPC with socio-demographic index (SDI) were separately evaluated by Pearson correlation analyses.

RESULTS:

We observed a marked increase in the ASIR of LC, increasing from 2.22 (95% CI 2.15-2.27) per 100,000 people in 1990 to 5.23 (95% CI 4.28-6.29) per 100,000 people in 2019, a percentage change of 135.4%. LC due to hepatitis C followed by alcohol use were the primary factors driving this increase. The ASIR and age-standardized death rates of LC showed a significant average annual increase of 3.0% (95% CI 2.7-3.2) and 2.6% (95% CI 2.5-2.8), respectively. There was a significant negative correlation between the SDI and the EAPC in ASIR (ρ = -0.40, p = 0.004) and age-standardized death rates (ρ = -0.46, p < 0.001). In 2019, drug and alcohol use, followed by elevated body mass index (BMI) were the primary risk factors for age-standardized DALY rates attributable to LC.

CONCLUSION:

The increased burden of LC in the US highlights the need for interventions. This is particularly important given that LC is mostly influenced by modifiable risk factors, such as drug and alcohol use, and elevated BMI. Our findings highlight the urgent need for public health interventions targeting socio-economic, lifestyle, and modifiable risk factors to mitigate the escalating burden of LC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hepáticas Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hepáticas Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Ano de publicação: 2024 Tipo de documento: Article